Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic transmission, dopaminergic (GO:0001963) | 6.47001060 |
2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.77293560 |
3 | prepulse inhibition (GO:0060134) | 5.65944165 |
4 | striatum development (GO:0021756) | 5.46570641 |
5 | * regulation of rhodopsin mediated signaling pathway (GO:0022400) | 5.40351545 |
6 | behavioral response to nicotine (GO:0035095) | 5.30860184 |
7 | * rhodopsin mediated signaling pathway (GO:0016056) | 5.28067701 |
8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.27947888 |
9 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.17005417 |
10 | regulation of synapse structural plasticity (GO:0051823) | 5.15121567 |
11 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.14265667 |
12 | synaptic vesicle maturation (GO:0016188) | 5.10921966 |
13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.94994815 |
14 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.93323616 |
15 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.89271124 |
16 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.89271124 |
17 | locomotory exploration behavior (GO:0035641) | 4.87199017 |
18 | adenosine receptor signaling pathway (GO:0001973) | 4.79470066 |
19 | response to amphetamine (GO:0001975) | 4.75218319 |
20 | positive regulation of neurotransmitter transport (GO:0051590) | 4.74992439 |
21 | retinal cone cell development (GO:0046549) | 4.74963748 |
22 | behavioral response to cocaine (GO:0048148) | 4.64960896 |
23 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.60974486 |
24 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.45990140 |
25 | auditory behavior (GO:0031223) | 4.45212974 |
26 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.44686997 |
27 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.42211642 |
28 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.35871039 |
29 | cAMP catabolic process (GO:0006198) | 4.35037203 |
30 | vocalization behavior (GO:0071625) | 4.29791642 |
31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.27154686 |
32 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.26821774 |
33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.23429811 |
34 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.19990724 |
35 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.18585957 |
36 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.14516436 |
37 | regulation of neurotransmitter uptake (GO:0051580) | 4.13781109 |
38 | protein localization to synapse (GO:0035418) | 4.12284431 |
39 | * dopamine receptor signaling pathway (GO:0007212) | 4.11718646 |
40 | response to auditory stimulus (GO:0010996) | 4.04086601 |
41 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.03263698 |
42 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.03263698 |
43 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.01662416 |
44 | regulation of female receptivity (GO:0045924) | 3.99966135 |
45 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.97552131 |
46 | neuron-neuron synaptic transmission (GO:0007270) | 3.97106538 |
47 | response to histamine (GO:0034776) | 3.96223942 |
48 | membrane hyperpolarization (GO:0060081) | 3.90983879 |
49 | positive regulation of membrane potential (GO:0045838) | 3.88247833 |
50 | cyclic nucleotide catabolic process (GO:0009214) | 3.87045409 |
51 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.86521832 |
52 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.85023354 |
53 | photoreceptor cell development (GO:0042461) | 3.81638066 |
54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.81316226 |
55 | synaptic vesicle exocytosis (GO:0016079) | 3.77450370 |
56 | regulation of glucokinase activity (GO:0033131) | 3.71150356 |
57 | regulation of hexokinase activity (GO:1903299) | 3.71150356 |
58 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.65791327 |
59 | protein complex biogenesis (GO:0070271) | 3.63801213 |
60 | regulation of postsynaptic membrane potential (GO:0060078) | 3.62303026 |
61 | female mating behavior (GO:0060180) | 3.62275056 |
62 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.62069607 |
63 | visual learning (GO:0008542) | 3.61995682 |
64 | eye photoreceptor cell development (GO:0042462) | 3.61504659 |
65 | photoreceptor cell maintenance (GO:0045494) | 3.61092193 |
66 | neurotransmitter secretion (GO:0007269) | 3.60697845 |
67 | long-term memory (GO:0007616) | 3.60538770 |
68 | dendritic spine morphogenesis (GO:0060997) | 3.59262443 |
69 | synaptic transmission, glutamatergic (GO:0035249) | 3.58450787 |
70 | platelet dense granule organization (GO:0060155) | 3.56993696 |
71 | neuromuscular process controlling balance (GO:0050885) | 3.55835315 |
72 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.54374183 |
73 | detection of light stimulus involved in visual perception (GO:0050908) | 3.53467770 |
74 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.53467770 |
75 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.51612332 |
76 | regulation of glutamate secretion (GO:0014048) | 3.48115666 |
77 | behavioral response to ethanol (GO:0048149) | 3.47779879 |
78 | transmission of nerve impulse (GO:0019226) | 3.46702190 |
79 | neuronal ion channel clustering (GO:0045161) | 3.46561454 |
80 | regulation of synaptic vesicle transport (GO:1902803) | 3.46555868 |
81 | behavioral fear response (GO:0001662) | 3.46085696 |
82 | behavioral defense response (GO:0002209) | 3.46085696 |
83 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.45396729 |
84 | respiratory chain complex IV assembly (GO:0008535) | 3.42366783 |
85 | cAMP metabolic process (GO:0046058) | 3.42091927 |
86 | peristalsis (GO:0030432) | 3.41898559 |
87 | visual behavior (GO:0007632) | 3.38304031 |
88 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.35390467 |
89 | cellular ketone body metabolic process (GO:0046950) | 3.35239575 |
90 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.33407971 |
91 | mechanosensory behavior (GO:0007638) | 3.31684835 |
92 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.31549760 |
93 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.31549760 |
94 | NADH dehydrogenase complex assembly (GO:0010257) | 3.31549760 |
95 | protein-chromophore linkage (GO:0018298) | 3.30149484 |
96 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.28415791 |
97 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.28381539 |
98 | long-term synaptic potentiation (GO:0060291) | 3.28191328 |
99 | protein polyglutamylation (GO:0018095) | 3.26656919 |
100 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.26193544 |
101 | tryptophan catabolic process (GO:0006569) | 3.25285593 |
102 | indole-containing compound catabolic process (GO:0042436) | 3.25285593 |
103 | indolalkylamine catabolic process (GO:0046218) | 3.25285593 |
104 | exploration behavior (GO:0035640) | 3.25253753 |
105 | DNA deamination (GO:0045006) | 3.24958961 |
106 | regulation of dopamine metabolic process (GO:0042053) | 3.24176764 |
107 | regulation of catecholamine metabolic process (GO:0042069) | 3.24176764 |
108 | response to pheromone (GO:0019236) | 3.21127631 |
109 | glycine transport (GO:0015816) | 3.20817388 |
110 | dopamine transport (GO:0015872) | 3.20320189 |
111 | regulation of synaptic plasticity (GO:0048167) | 3.20144186 |
112 | cGMP metabolic process (GO:0046068) | 3.19557533 |
113 | drinking behavior (GO:0042756) | 3.19262391 |
114 | axoneme assembly (GO:0035082) | 3.18902480 |
115 | neuronal action potential propagation (GO:0019227) | 3.17402489 |
116 | response to amine (GO:0014075) | 3.17212047 |
117 | regulation of neurotransmitter transport (GO:0051588) | 3.17079239 |
118 | * phototransduction (GO:0007602) | 3.16853266 |
119 | kynurenine metabolic process (GO:0070189) | 3.16703416 |
120 | negative regulation of dendrite development (GO:2000171) | 3.15143249 |
121 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.14073643 |
122 | L-fucose catabolic process (GO:0042355) | 3.12439791 |
123 | fucose catabolic process (GO:0019317) | 3.12439791 |
124 | L-fucose metabolic process (GO:0042354) | 3.12439791 |
125 | cytochrome complex assembly (GO:0017004) | 3.11459195 |
126 | kidney morphogenesis (GO:0060993) | 3.07276709 |
127 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.06387019 |
128 | protein neddylation (GO:0045116) | 3.05423713 |
129 | indolalkylamine metabolic process (GO:0006586) | 3.04169625 |
130 | inositol phosphate catabolic process (GO:0071545) | 3.03275455 |
131 | ketone body metabolic process (GO:1902224) | 3.03104532 |
132 | sulfation (GO:0051923) | 3.02232040 |
133 | glycerophospholipid catabolic process (GO:0046475) | 3.00082154 |
134 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.98352531 |
135 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.94862921 |
136 | reflex (GO:0060004) | 2.94687366 |
137 | epithelial cilium movement (GO:0003351) | 2.92064449 |
138 | protein localization to cilium (GO:0061512) | 2.87533319 |
139 | regulation of mesoderm development (GO:2000380) | 2.80302275 |
140 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.79750255 |
141 | inositol phosphate dephosphorylation (GO:0046855) | 2.79750255 |
142 | presynaptic membrane assembly (GO:0097105) | 2.79161525 |
143 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.79001905 |
144 | negative regulation of telomere maintenance (GO:0032205) | 2.76011530 |
145 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.70652937 |
146 | nonmotile primary cilium assembly (GO:0035058) | 2.68029478 |
147 | negative regulation of appetite (GO:0032099) | 2.67917068 |
148 | negative regulation of response to food (GO:0032096) | 2.67917068 |
149 | gamma-aminobutyric acid transport (GO:0015812) | 2.65682919 |
150 | tryptophan metabolic process (GO:0006568) | 2.61588963 |
151 | polyol catabolic process (GO:0046174) | 2.60794870 |
152 | GPI anchor metabolic process (GO:0006505) | 2.60724489 |
153 | neuronal action potential (GO:0019228) | 2.59917780 |
154 | piRNA metabolic process (GO:0034587) | 2.58457977 |
155 | cellular response to ATP (GO:0071318) | 2.57215407 |
156 | keratinocyte development (GO:0003334) | 2.56994802 |
157 | cilium movement (GO:0003341) | 2.56099309 |
158 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.56037713 |
159 | regulation of action potential (GO:0098900) | 2.54983992 |
160 | nephron tubule morphogenesis (GO:0072078) | 2.53574233 |
161 | nephron epithelium morphogenesis (GO:0072088) | 2.53574233 |
162 | presynaptic membrane organization (GO:0097090) | 2.51426242 |
163 | protein K6-linked ubiquitination (GO:0085020) | 2.51324549 |
164 | cilium morphogenesis (GO:0060271) | 2.50246948 |
165 | mannosylation (GO:0097502) | 2.49363533 |
166 | insulin secretion (GO:0030073) | 2.47528064 |
167 | cilium organization (GO:0044782) | 2.47474146 |
168 | aromatic amino acid family catabolic process (GO:0009074) | 2.47017243 |
169 | endocrine pancreas development (GO:0031018) | 2.46775179 |
170 | prostate gland growth (GO:0060736) | 2.46648463 |
171 | lactate metabolic process (GO:0006089) | 2.45384424 |
172 | adaptation of signaling pathway (GO:0023058) | 2.44699496 |
173 | indole-containing compound metabolic process (GO:0042430) | 2.44489752 |
174 | positive regulation of fatty acid transport (GO:2000193) | 2.43109715 |
175 | regulation of cilium movement (GO:0003352) | 2.42403767 |
176 | positive regulation of prostaglandin secretion (GO:0032308) | 2.40146826 |
177 | synaptic transmission, cholinergic (GO:0007271) | 2.39996259 |
178 | positive regulation of meiosis (GO:0045836) | 2.39426925 |
179 | cilium assembly (GO:0042384) | 2.38860668 |
180 | proline transport (GO:0015824) | 2.38403593 |
181 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.38015939 |
182 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.38015939 |
183 | replication fork processing (GO:0031297) | 2.37430138 |
184 | calcium ion import (GO:0070509) | 2.36061480 |
185 | startle response (GO:0001964) | 2.35763841 |
186 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.35708332 |
187 | amine catabolic process (GO:0009310) | 2.35309289 |
188 | cellular biogenic amine catabolic process (GO:0042402) | 2.35309289 |
189 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.34642599 |
190 | spinal cord motor neuron differentiation (GO:0021522) | 2.34185040 |
191 | dentate gyrus development (GO:0021542) | 2.31604074 |
192 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.31058062 |
193 | S-adenosylmethionine metabolic process (GO:0046500) | 2.30565372 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.03510082 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.24747810 |
3 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.61049330 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.47280616 |
5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.39157577 |
6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.00579900 |
7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.96755390 |
8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.91651134 |
9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.84751121 |
10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.72785663 |
11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.65074957 |
12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57809074 |
13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.56984550 |
14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54856305 |
15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54856305 |
16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49736170 |
17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.46233150 |
18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42224471 |
19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39051932 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.37894424 |
21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.37420774 |
22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29821716 |
23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26872318 |
24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.25909490 |
25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.22845864 |
26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19932147 |
27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.19056659 |
28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.18097448 |
29 | FUS_26573619_Chip-Seq_HEK293_Human | 2.16490159 |
30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13603325 |
31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10290759 |
32 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.09827448 |
33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.07815812 |
34 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.06119384 |
35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01950713 |
36 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.99315733 |
37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.95461308 |
38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88738583 |
39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81855929 |
40 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.80068553 |
41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.73622981 |
42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.70632316 |
43 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.69783269 |
44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.64935139 |
45 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.63968807 |
46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.61579439 |
47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.57935790 |
48 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.57313098 |
49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53199083 |
50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53121047 |
51 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.48297230 |
52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.47906555 |
53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.47010974 |
54 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.45525904 |
55 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.45198797 |
56 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.44053576 |
57 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.44053576 |
58 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.43289373 |
59 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41332847 |
60 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40539169 |
61 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.40175930 |
62 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.38899497 |
63 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.38111146 |
64 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36810147 |
65 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36810147 |
66 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.36367610 |
67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35844543 |
68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35433463 |
69 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.34494306 |
70 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.34494306 |
71 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.33924927 |
72 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.31844674 |
73 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30214726 |
74 | AR_19668381_ChIP-Seq_PC3_Human | 1.30180095 |
75 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29222240 |
76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27831460 |
77 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27062560 |
78 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.25603424 |
79 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.25116818 |
80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.25059399 |
81 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25050097 |
82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24649151 |
83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22627532 |
84 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.20967063 |
85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.20612324 |
86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20082805 |
87 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19995150 |
88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19236839 |
89 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18159951 |
90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17660173 |
91 | AR_20517297_ChIP-Seq_VCAP_Human | 1.16592407 |
92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16051814 |
93 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.14783966 |
94 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14773028 |
95 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14040589 |
96 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.13617167 |
97 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13284447 |
98 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13243496 |
99 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12213154 |
100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.11994829 |
101 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11397282 |
102 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.10232503 |
103 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09560908 |
104 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.09358871 |
105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08235676 |
106 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07914355 |
107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07524933 |
108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07235095 |
109 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07191493 |
110 | NCOR_22424771_ChIP-Seq_293T_Human | 1.07023914 |
111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.06724890 |
112 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.06539389 |
113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05019885 |
114 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04844980 |
115 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04630243 |
116 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.04390163 |
117 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04190004 |
118 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03457576 |
119 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03457576 |
120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02867395 |
121 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02482918 |
122 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02060461 |
123 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01340520 |
124 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01320615 |
125 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.00912309 |
126 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00743430 |
127 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00687795 |
128 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00601036 |
129 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00264004 |
130 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00217267 |
131 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00134289 |
132 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99954401 |
133 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99890497 |
134 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99545286 |
135 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98326618 |
136 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.98217041 |
137 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97729211 |
138 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97446275 |
139 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97179680 |
140 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97153437 |
141 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96782024 |
142 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96150250 |
143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96057045 |
144 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95711102 |
145 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95485394 |
146 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.94863247 |
147 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94178239 |
148 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93781640 |
149 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93291398 |
150 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92664539 |
151 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92024897 |
152 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91554119 |
153 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89052700 |
154 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89009939 |
155 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88863903 |
156 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88777978 |
157 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.87735749 |
158 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87020442 |
159 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86911220 |
160 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86736483 |
161 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86430798 |
162 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84997746 |
163 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.84785382 |
164 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84673638 |
165 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83645770 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002822_catalepsy | 8.39028699 |
2 | MP0004859_abnormal_synaptic_plasticity | 5.23023965 |
3 | * MP0005551_abnormal_eye_electrophysiolog | 4.03201262 |
4 | MP0003195_calcinosis | 3.52147052 |
5 | MP0003635_abnormal_synaptic_transmissio | 3.51021482 |
6 | MP0003011_delayed_dark_adaptation | 3.48559537 |
7 | MP0003880_abnormal_central_pattern | 3.47333160 |
8 | MP0009745_abnormal_behavioral_response | 3.30736910 |
9 | MP0005423_abnormal_somatic_nervous | 3.17749252 |
10 | MP0002837_dystrophic_cardiac_calcinosis | 3.12591798 |
11 | MP0002063_abnormal_learning/memory/cond | 3.03610915 |
12 | MP0008877_abnormal_DNA_methylation | 2.92758153 |
13 | MP0004270_analgesia | 2.81917878 |
14 | MP0001486_abnormal_startle_reflex | 2.76966379 |
15 | MP0005253_abnormal_eye_physiology | 2.69343102 |
16 | MP0002064_seizures | 2.60394725 |
17 | MP0005646_abnormal_pituitary_gland | 2.57962286 |
18 | MP0002572_abnormal_emotion/affect_behav | 2.51898255 |
19 | MP0009046_muscle_twitch | 2.49365680 |
20 | MP0002102_abnormal_ear_morphology | 2.48076553 |
21 | MP0006072_abnormal_retinal_apoptosis | 2.44627305 |
22 | MP0001529_abnormal_vocalization | 2.44513609 |
23 | MP0002272_abnormal_nervous_system | 2.32201673 |
24 | MP0002909_abnormal_adrenal_gland | 2.20859601 |
25 | MP0001968_abnormal_touch/_nociception | 2.15363851 |
26 | MP0003136_yellow_coat_color | 2.13631470 |
27 | MP0002876_abnormal_thyroid_physiology | 2.08432467 |
28 | MP0005084_abnormal_gallbladder_morpholo | 1.99666786 |
29 | MP0005409_darkened_coat_color | 1.97382664 |
30 | MP0005379_endocrine/exocrine_gland_phen | 1.97271184 |
31 | MP0001984_abnormal_olfaction | 1.93948988 |
32 | MP0001188_hyperpigmentation | 1.90271395 |
33 | MP0002090_abnormal_vision | 1.90149078 |
34 | MP0002734_abnormal_mechanical_nocicepti | 1.88171788 |
35 | MP0004924_abnormal_behavior | 1.84563771 |
36 | MP0005386_behavior/neurological_phenoty | 1.84563771 |
37 | MP0002163_abnormal_gland_morphology | 1.82961925 |
38 | MP0001501_abnormal_sleep_pattern | 1.81495687 |
39 | MP0004133_heterotaxia | 1.74648149 |
40 | MP0002638_abnormal_pupillary_reflex | 1.62135524 |
41 | MP0002229_neurodegeneration | 1.59259434 |
42 | MP0002938_white_spotting | 1.57928385 |
43 | MP0002557_abnormal_social/conspecific_i | 1.57913858 |
44 | MP0005174_abnormal_tail_pigmentation | 1.53950330 |
45 | MP0001970_abnormal_pain_threshold | 1.53358603 |
46 | MP0003646_muscle_fatigue | 1.53346919 |
47 | MP0001502_abnormal_circadian_rhythm | 1.50119827 |
48 | MP0008569_lethality_at_weaning | 1.49102069 |
49 | MP0000372_irregular_coat_pigmentation | 1.47005227 |
50 | MP0005195_abnormal_posterior_eye | 1.45332231 |
51 | MP0004885_abnormal_endolymph | 1.42664535 |
52 | MP0001485_abnormal_pinna_reflex | 1.42503241 |
53 | MP0002882_abnormal_neuron_morphology | 1.42367595 |
54 | MP0004811_abnormal_neuron_physiology | 1.39253154 |
55 | MP0002067_abnormal_sensory_capabilities | 1.37922732 |
56 | MP0002733_abnormal_thermal_nociception | 1.37158903 |
57 | MP0004147_increased_porphyrin_level | 1.35043209 |
58 | MP0002928_abnormal_bile_duct | 1.33330383 |
59 | MP0002160_abnormal_reproductive_system | 1.30554882 |
60 | MP0002693_abnormal_pancreas_physiology | 1.28831371 |
61 | MP0005645_abnormal_hypothalamus_physiol | 1.28373193 |
62 | MP0004145_abnormal_muscle_electrophysio | 1.27323552 |
63 | MP0009780_abnormal_chondrocyte_physiolo | 1.27278214 |
64 | MP0000427_abnormal_hair_cycle | 1.26065848 |
65 | MP0002736_abnormal_nociception_after | 1.23503904 |
66 | MP0002277_abnormal_respiratory_mucosa | 1.22010571 |
67 | MP0001440_abnormal_grooming_behavior | 1.18407394 |
68 | MP0001177_atelectasis | 1.17804337 |
69 | MP0001905_abnormal_dopamine_level | 1.17569561 |
70 | MP0005389_reproductive_system_phenotype | 1.17330731 |
71 | MP0003075_altered_response_to | 1.16595565 |
72 | MP0005332_abnormal_amino_acid | 1.14628847 |
73 | MP0001324_abnormal_eye_pigmentation | 1.13881794 |
74 | MP0003879_abnormal_hair_cell | 1.13440361 |
75 | MP0008995_early_reproductive_senescence | 1.11973833 |
76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10621334 |
77 | MP0008872_abnormal_physiological_respon | 1.10069497 |
78 | MP0003633_abnormal_nervous_system | 1.09490156 |
79 | MP0002066_abnormal_motor_capabilities/c | 1.09288474 |
80 | MP0004215_abnormal_myocardial_fiber | 1.09084050 |
81 | MP0001944_abnormal_pancreas_morphology | 1.08872230 |
82 | MP0002752_abnormal_somatic_nervous | 1.08236535 |
83 | MP0002184_abnormal_innervation | 1.07949984 |
84 | MP0000013_abnormal_adipose_tissue | 1.07843016 |
85 | MP0002138_abnormal_hepatobiliary_system | 1.06508912 |
86 | MP0005075_abnormal_melanosome_morpholog | 1.06270377 |
87 | MP0003787_abnormal_imprinting | 1.01836118 |
88 | MP0005499_abnormal_olfactory_system | 1.01121268 |
89 | MP0005394_taste/olfaction_phenotype | 1.01121268 |
90 | MP0005391_vision/eye_phenotype | 1.00924227 |
91 | MP0003121_genomic_imprinting | 1.00683307 |
92 | MP0005365_abnormal_bile_salt | 1.00208724 |
93 | MP0005167_abnormal_blood-brain_barrier | 0.99894596 |
94 | MP0001919_abnormal_reproductive_system | 0.99318988 |
95 | MP0000955_abnormal_spinal_cord | 0.99120738 |
96 | MP0010329_abnormal_lipoprotein_level | 0.98840376 |
97 | MP0000383_abnormal_hair_follicle | 0.98348783 |
98 | MP0001986_abnormal_taste_sensitivity | 0.97462411 |
99 | MP0002735_abnormal_chemical_nociception | 0.97418662 |
100 | MP0008874_decreased_physiological_sensi | 0.96351335 |
101 | MP0000569_abnormal_digit_pigmentation | 0.96295284 |
102 | MP0004085_abnormal_heartbeat | 0.93923209 |
103 | MP0003283_abnormal_digestive_organ | 0.91724551 |
104 | MP0008058_abnormal_DNA_repair | 0.91006062 |
105 | MP0003878_abnormal_ear_physiology | 0.90551792 |
106 | MP0005377_hearing/vestibular/ear_phenot | 0.90551792 |
107 | MP0000631_abnormal_neuroendocrine_gland | 0.89958211 |
108 | MP0008961_abnormal_basal_metabolism | 0.89716631 |
109 | MP0003119_abnormal_digestive_system | 0.88292115 |
110 | MP0002069_abnormal_eating/drinking_beha | 0.88029273 |
111 | MP0000230_abnormal_systemic_arterial | 0.87845134 |
112 | MP0005448_abnormal_energy_balance | 0.87147759 |
113 | MP0005410_abnormal_fertilization | 0.85709353 |
114 | MP0000778_abnormal_nervous_system | 0.85693556 |
115 | MP0006292_abnormal_olfactory_placode | 0.85134800 |
116 | MP0005085_abnormal_gallbladder_physiolo | 0.85005885 |
117 | MP0002751_abnormal_autonomic_nervous | 0.83907587 |
118 | MP0002254_reproductive_system_inflammat | 0.82406752 |
119 | MP0004142_abnormal_muscle_tone | 0.82078489 |
120 | MP0005636_abnormal_mineral_homeostasis | 0.81854899 |
121 | MP0003631_nervous_system_phenotype | 0.80591091 |
122 | MP0003890_abnormal_embryonic-extraembry | 0.80018198 |
123 | MP0005535_abnormal_body_temperature | 0.79900525 |
124 | MP0001756_abnormal_urination | 0.78046043 |
125 | MP0003718_maternal_effect | 0.77739758 |
126 | MP0010386_abnormal_urinary_bladder | 0.77286312 |
127 | MP0002152_abnormal_brain_morphology | 0.75814466 |
128 | MP0003634_abnormal_glial_cell | 0.72517513 |
129 | MP0003690_abnormal_glial_cell | 0.72044142 |
130 | MP0004742_abnormal_vestibular_system | 0.65531657 |
131 | MP0002653_abnormal_ependyma_morphology | 0.58809807 |
132 | MP0004043_abnormal_pH_regulation | 0.58794383 |
133 | MP0000920_abnormal_myelination | 0.57693829 |
134 | MP0006276_abnormal_autonomic_nervous | 0.57097080 |
135 | MP0001963_abnormal_hearing_physiology | 0.56397192 |
136 | MP0003137_abnormal_impulse_conducting | 0.51453163 |
137 | MP0005248_abnormal_Harderian_gland | 0.46914333 |
138 | MP0003122_maternal_imprinting | 0.46740106 |
139 | MP0004233_abnormal_muscle_weight | 0.45871739 |
140 | MP0005310_abnormal_salivary_gland | 0.43642638 |
141 | MP0001664_abnormal_digestion | 0.43504648 |
142 | MP0003329_amyloid_beta_deposits | 0.42768515 |
143 | MP0004858_abnormal_nervous_system | 0.41729921 |
144 | MP0003950_abnormal_plasma_membrane | 0.41671608 |
145 | MP0003045_fibrosis | 0.39601323 |
146 | MP0005166_decreased_susceptibility_to | 0.39230181 |
147 | MP0003632_abnormal_nervous_system | 0.38694516 |
148 | MP0001943_abnormal_respiration | 0.38676236 |
149 | MP0000003_abnormal_adipose_tissue | 0.38066927 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Congenital stationary night blindness (HP:0007642) | 8.43675447 |
2 | Bony spicule pigmentary retinopathy (HP:0007737) | 6.95193591 |
3 | Myokymia (HP:0002411) | 6.94767875 |
4 | Central scotoma (HP:0000603) | 6.35122108 |
5 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.18773018 |
6 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.96147981 |
7 | Dyschromatopsia (HP:0007641) | 5.95922351 |
8 | Focal motor seizures (HP:0011153) | 5.78277479 |
9 | Scotoma (HP:0000575) | 5.26148561 |
10 | Abnormality of macular pigmentation (HP:0008002) | 5.23275676 |
11 | Pigmentary retinal degeneration (HP:0001146) | 4.79015938 |
12 | Decreased central vision (HP:0007663) | 4.50351143 |
13 | Attenuation of retinal blood vessels (HP:0007843) | 4.46752687 |
14 | Chorioretinal atrophy (HP:0000533) | 4.25981811 |
15 | Focal seizures (HP:0007359) | 4.24120695 |
16 | Pancreatic cysts (HP:0001737) | 4.11222046 |
17 | Pendular nystagmus (HP:0012043) | 4.09721730 |
18 | Pancreatic fibrosis (HP:0100732) | 3.89011930 |
19 | Abolished electroretinogram (ERG) (HP:0000550) | 3.88874597 |
20 | Molar tooth sign on MRI (HP:0002419) | 3.65389315 |
21 | Abnormality of midbrain morphology (HP:0002418) | 3.65389315 |
22 | True hermaphroditism (HP:0010459) | 3.63744936 |
23 | Nephronophthisis (HP:0000090) | 3.53073476 |
24 | Febrile seizures (HP:0002373) | 3.43509404 |
25 | Type II diabetes mellitus (HP:0005978) | 3.43306997 |
26 | * Photophobia (HP:0000613) | 3.41575338 |
27 | Annular pancreas (HP:0001734) | 3.37730813 |
28 | Resting tremor (HP:0002322) | 3.37193593 |
29 | Epileptic encephalopathy (HP:0200134) | 3.36423989 |
30 | Torticollis (HP:0000473) | 3.34579085 |
31 | Severe visual impairment (HP:0001141) | 3.28323144 |
32 | Poor eye contact (HP:0000817) | 3.16435061 |
33 | Macular degeneration (HP:0000608) | 3.15887822 |
34 | Visual hallucinations (HP:0002367) | 3.11514300 |
35 | Dysdiadochokinesis (HP:0002075) | 3.05655117 |
36 | Anxiety (HP:0000739) | 3.02934007 |
37 | Broad-based gait (HP:0002136) | 3.02634115 |
38 | Choroideremia (HP:0001139) | 3.00829998 |
39 | Prolonged QT interval (HP:0001657) | 2.98440310 |
40 | Type II lissencephaly (HP:0007260) | 2.96312084 |
41 | Abnormality of the renal cortex (HP:0011035) | 2.92327722 |
42 | Action tremor (HP:0002345) | 2.91945303 |
43 | Depression (HP:0000716) | 2.87877746 |
44 | Abnormality of the renal medulla (HP:0100957) | 2.86174515 |
45 | Methylmalonic acidemia (HP:0002912) | 2.83275769 |
46 | Posterior subcapsular cataract (HP:0007787) | 2.83148213 |
47 | Gaze-evoked nystagmus (HP:0000640) | 2.82354415 |
48 | Focal dystonia (HP:0004373) | 2.77730220 |
49 | Retinitis pigmentosa (HP:0000510) | 2.77403310 |
50 | Impaired social interactions (HP:0000735) | 2.76516180 |
51 | Abnormal social behavior (HP:0012433) | 2.76516180 |
52 | Craniofacial dystonia (HP:0012179) | 2.74620649 |
53 | Large for gestational age (HP:0001520) | 2.72703006 |
54 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.70044902 |
55 | Ankle clonus (HP:0011448) | 2.69813990 |
56 | Keratoconus (HP:0000563) | 2.67874226 |
57 | Increased corneal curvature (HP:0100692) | 2.67874226 |
58 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67744699 |
59 | Vitreoretinal degeneration (HP:0000655) | 2.64241444 |
60 | Constricted visual fields (HP:0001133) | 2.61774508 |
61 | Abnormal EKG (HP:0003115) | 2.61060469 |
62 | Acute necrotizing encephalopathy (HP:0006965) | 2.59858160 |
63 | Generalized tonic-clonic seizures (HP:0002069) | 2.58039858 |
64 | Progressive cerebellar ataxia (HP:0002073) | 2.56370996 |
65 | Progressive macrocephaly (HP:0004481) | 2.56130616 |
66 | Abnormal drinking behavior (HP:0030082) | 2.54360140 |
67 | Polydipsia (HP:0001959) | 2.54360140 |
68 | Hypothermia (HP:0002045) | 2.50846868 |
69 | Ankyloglossia (HP:0010296) | 2.50496554 |
70 | Cone-rod dystrophy (HP:0000548) | 2.48638195 |
71 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.48005822 |
72 | Truncal ataxia (HP:0002078) | 2.46125148 |
73 | Stereotypic behavior (HP:0000733) | 2.44583720 |
74 | Tubular atrophy (HP:0000092) | 2.41571758 |
75 | Ketoacidosis (HP:0001993) | 2.41520730 |
76 | Cystic liver disease (HP:0006706) | 2.40681793 |
77 | Lower limb amyotrophy (HP:0007210) | 2.38966644 |
78 | 3-Methylglutaconic aciduria (HP:0003535) | 2.38218760 |
79 | Progressive inability to walk (HP:0002505) | 2.37226377 |
80 | Mitochondrial inheritance (HP:0001427) | 2.36856437 |
81 | Methylmalonic aciduria (HP:0012120) | 2.36542599 |
82 | Scanning speech (HP:0002168) | 2.35838898 |
83 | Furrowed tongue (HP:0000221) | 2.35602968 |
84 | Sclerocornea (HP:0000647) | 2.34225690 |
85 | Postural instability (HP:0002172) | 2.34189274 |
86 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.33977607 |
87 | Retinal atrophy (HP:0001105) | 2.33581130 |
88 | Acute encephalopathy (HP:0006846) | 2.32212814 |
89 | Intestinal atresia (HP:0011100) | 2.32194788 |
90 | Renal cortical cysts (HP:0000803) | 2.30839799 |
91 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.29972024 |
92 | Increased CSF lactate (HP:0002490) | 2.26601621 |
93 | Optic nerve hypoplasia (HP:0000609) | 2.23373920 |
94 | Gait imbalance (HP:0002141) | 2.23231119 |
95 | Abnormality of vitamin B metabolism (HP:0004340) | 2.21900970 |
96 | Absence seizures (HP:0002121) | 2.21487708 |
97 | Chronic hepatic failure (HP:0100626) | 2.20088035 |
98 | Inability to walk (HP:0002540) | 2.19710706 |
99 | Anencephaly (HP:0002323) | 2.19677930 |
100 | Papilledema (HP:0001085) | 2.18555826 |
101 | Dysmetric saccades (HP:0000641) | 2.17715316 |
102 | Agitation (HP:0000713) | 2.17459249 |
103 | Pointed chin (HP:0000307) | 2.17364694 |
104 | Hemiparesis (HP:0001269) | 2.16257215 |
105 | Dysmetria (HP:0001310) | 2.14629941 |
106 | Male pseudohermaphroditism (HP:0000037) | 2.14229400 |
107 | Lissencephaly (HP:0001339) | 2.14109370 |
108 | Hypoplasia of the fovea (HP:0007750) | 2.11480619 |
109 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.11480619 |
110 | Congenital primary aphakia (HP:0007707) | 2.11309075 |
111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11296323 |
112 | Progressive visual loss (HP:0000529) | 2.11192999 |
113 | Hypoglycemic seizures (HP:0002173) | 2.10462378 |
114 | Dialeptic seizures (HP:0011146) | 2.09582718 |
115 | Impaired smooth pursuit (HP:0007772) | 2.08872862 |
116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08328812 |
117 | Abnormality of alanine metabolism (HP:0010916) | 2.08328812 |
118 | Hyperalaninemia (HP:0003348) | 2.08328812 |
119 | Hypoglycemic coma (HP:0001325) | 2.06940923 |
120 | Abnormal biliary tract physiology (HP:0012439) | 2.06511877 |
121 | Bile duct proliferation (HP:0001408) | 2.06511877 |
122 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.05448132 |
123 | Abnormality of the labia minora (HP:0012880) | 2.04824388 |
124 | Limb hypertonia (HP:0002509) | 2.04435208 |
125 | Genetic anticipation (HP:0003743) | 2.02336605 |
126 | Genital tract atresia (HP:0001827) | 2.01423188 |
127 | Distal lower limb amyotrophy (HP:0008944) | 2.00424432 |
128 | Ketosis (HP:0001946) | 1.98922202 |
129 | Polyuria (HP:0000103) | 1.98539102 |
130 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.96484284 |
131 | Polygenic inheritance (HP:0010982) | 1.96359629 |
132 | Vaginal atresia (HP:0000148) | 1.95341973 |
133 | Impaired vibratory sensation (HP:0002495) | 1.94571414 |
134 | Bradykinesia (HP:0002067) | 1.93515856 |
135 | Congenital, generalized hypertrichosis (HP:0004540) | 1.93419772 |
136 | Abnormality of the fovea (HP:0000493) | 1.92991447 |
137 | Congenital hepatic fibrosis (HP:0002612) | 1.92278237 |
138 | Oligodactyly (hands) (HP:0001180) | 1.91178417 |
139 | Hepatic necrosis (HP:0002605) | 1.90913595 |
140 | Nephrogenic diabetes insipidus (HP:0009806) | 1.90828107 |
141 | Urinary urgency (HP:0000012) | 1.90712943 |
142 | Hypomagnesemia (HP:0002917) | 1.90436569 |
143 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.90061806 |
144 | Congenital sensorineural hearing impairment (HP:0008527) | 1.88177838 |
145 | Thyroiditis (HP:0100646) | 1.87991372 |
146 | Intention tremor (HP:0002080) | 1.87649383 |
147 | Septo-optic dysplasia (HP:0100842) | 1.87046556 |
148 | Abnormal eating behavior (HP:0100738) | 1.86793997 |
149 | Hepatocellular necrosis (HP:0001404) | 1.86002922 |
150 | Spastic gait (HP:0002064) | 1.85867397 |
151 | Limb dystonia (HP:0002451) | 1.84323537 |
152 | Atrioventricular block (HP:0001678) | 1.83468919 |
153 | Hyperventilation (HP:0002883) | 1.83441857 |
154 | Cerebellar dysplasia (HP:0007033) | 1.83321457 |
155 | Atonic seizures (HP:0010819) | 1.83163527 |
156 | Medial flaring of the eyebrow (HP:0010747) | 1.82208666 |
157 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.81731296 |
158 | Lipid accumulation in hepatocytes (HP:0006561) | 1.81539340 |
159 | Abnormal ciliary motility (HP:0012262) | 1.80533391 |
160 | Supranuclear gaze palsy (HP:0000605) | 1.79755243 |
161 | Short tibia (HP:0005736) | 1.78849423 |
162 | Subcapsular cataract (HP:0000523) | 1.78334535 |
163 | Hypoalbuminemia (HP:0003073) | 1.78233480 |
164 | Abnormal albumin level (HP:0012116) | 1.78233480 |
165 | Glycosuria (HP:0003076) | 1.78147656 |
166 | Abnormality of urine glucose concentration (HP:0011016) | 1.78147656 |
167 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.77980472 |
168 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.77980472 |
169 | Optic disc pallor (HP:0000543) | 1.77894692 |
170 | Acute lymphatic leukemia (HP:0006721) | 1.77155746 |
171 | Abnormality of oral frenula (HP:0000190) | 1.77011338 |
172 | Polyphagia (HP:0002591) | 1.75995127 |
173 | Severe muscular hypotonia (HP:0006829) | 1.74097273 |
174 | Wide nasal bridge (HP:0000431) | 1.72884109 |
175 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.71979423 |
176 | Abnormality of the pons (HP:0007361) | 1.71575040 |
177 | Obsessive-compulsive behavior (HP:0000722) | 1.66919871 |
178 | Horizontal nystagmus (HP:0000666) | 1.65115209 |
179 | Mutism (HP:0002300) | 1.64338083 |
180 | Atrial fibrillation (HP:0005110) | 1.64122515 |
181 | Heart block (HP:0012722) | 1.63536935 |
182 | Megalencephaly (HP:0001355) | 1.63003751 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 7.59082740 |
2 | FRK | 5.85204035 |
3 | NTRK3 | 4.07343941 |
4 | ZAK | 2.91066225 |
5 | PRKD3 | 2.79228605 |
6 | MAP3K9 | 2.77824514 |
7 | BMPR1B | 2.54786300 |
8 | TLK1 | 2.53968378 |
9 | GRK1 | 2.53837558 |
10 | DAPK2 | 2.47783505 |
11 | MAP4K2 | 2.47009480 |
12 | NUAK1 | 2.46756902 |
13 | RIPK4 | 2.39886022 |
14 | CAMKK1 | 2.36535750 |
15 | KSR2 | 2.17261397 |
16 | FES | 2.06728423 |
17 | FGFR2 | 2.01663183 |
18 | TNIK | 1.99836632 |
19 | MST4 | 1.87044203 |
20 | SIK2 | 1.85500830 |
21 | MINK1 | 1.84179509 |
22 | MAP3K13 | 1.83530807 |
23 | TAOK3 | 1.83506160 |
24 | ACVR1B | 1.81821716 |
25 | PINK1 | 1.80761402 |
26 | MAP3K4 | 1.80152404 |
27 | NTRK2 | 1.73456369 |
28 | WNK4 | 1.70731338 |
29 | PRPF4B | 1.64508571 |
30 | MARK1 | 1.59428044 |
31 | KSR1 | 1.54624154 |
32 | CDK5 | 1.54510704 |
33 | SGK2 | 1.52994937 |
34 | CAMKK2 | 1.49274707 |
35 | MAP2K7 | 1.48762142 |
36 | MAP3K2 | 1.48727148 |
37 | PAK6 | 1.47222765 |
38 | ARAF | 1.45688615 |
39 | SGK223 | 1.43807787 |
40 | SGK494 | 1.43807787 |
41 | TAOK1 | 1.39489149 |
42 | BMPR2 | 1.32662375 |
43 | SGK3 | 1.31702797 |
44 | NTRK1 | 1.29263658 |
45 | DAPK1 | 1.28682846 |
46 | PHKG1 | 1.28080142 |
47 | PHKG2 | 1.28080142 |
48 | PRKCH | 1.25482587 |
49 | PAK3 | 1.23780212 |
50 | STK38 | 1.23491842 |
51 | NLK | 1.22968745 |
52 | TXK | 1.20902882 |
53 | VRK1 | 1.16044317 |
54 | NEK6 | 1.15209015 |
55 | MKNK2 | 1.14441481 |
56 | TRIM28 | 1.14419457 |
57 | CSNK1G1 | 1.04414854 |
58 | DYRK2 | 1.03516675 |
59 | TNK2 | 1.02851715 |
60 | SIK3 | 0.99985721 |
61 | SGK1 | 0.99438859 |
62 | OBSCN | 0.97455175 |
63 | TYRO3 | 0.94607211 |
64 | TIE1 | 0.94189225 |
65 | OXSR1 | 0.93305709 |
66 | STK38L | 0.93041114 |
67 | STK16 | 0.92869990 |
68 | STK39 | 0.92522037 |
69 | CSNK1G2 | 0.91980422 |
70 | RAF1 | 0.89025550 |
71 | CSNK1G3 | 0.87134737 |
72 | MARK2 | 0.86535635 |
73 | PLK3 | 0.85854431 |
74 | MAPK13 | 0.85055742 |
75 | PRKCG | 0.84285175 |
76 | CAMK1 | 0.81027205 |
77 | PNCK | 0.80757712 |
78 | STK3 | 0.80205863 |
79 | PRKD2 | 0.77023563 |
80 | STK11 | 0.76603210 |
81 | BCKDK | 0.76432658 |
82 | MAP2K4 | 0.75078389 |
83 | UHMK1 | 0.74693386 |
84 | MAP2K6 | 0.73596033 |
85 | NME1 | 0.73166109 |
86 | MAP3K1 | 0.72642730 |
87 | WNK1 | 0.71899922 |
88 | CAMK2A | 0.71750671 |
89 | INSRR | 0.70786156 |
90 | CASK | 0.69073719 |
91 | NEK2 | 0.68107940 |
92 | PRKCQ | 0.67013690 |
93 | PRKCZ | 0.65835175 |
94 | PDPK1 | 0.64939031 |
95 | RPS6KA3 | 0.64508482 |
96 | EPHA3 | 0.64288360 |
97 | CDK18 | 0.64183017 |
98 | BRSK2 | 0.63299811 |
99 | ALK | 0.63012163 |
100 | MAPK15 | 0.62927010 |
101 | IRAK2 | 0.62780530 |
102 | PDK1 | 0.61994538 |
103 | TGFBR1 | 0.61212166 |
104 | RPS6KA5 | 0.60970095 |
105 | CDK15 | 0.60843370 |
106 | GRK5 | 0.59479610 |
107 | CAMK4 | 0.58284038 |
108 | PKN1 | 0.58017833 |
109 | CAMK2B | 0.57529361 |
110 | CSNK1A1L | 0.57507957 |
111 | RET | 0.56696211 |
112 | IKBKB | 0.55857230 |
113 | VRK2 | 0.55813957 |
114 | PRKCI | 0.55741896 |
115 | CDC42BPA | 0.55440972 |
116 | HIPK2 | 0.55074843 |
117 | CDK14 | 0.54184909 |
118 | MAPK7 | 0.54152089 |
119 | NEK1 | 0.54053459 |
120 | AKT3 | 0.53998167 |
121 | PRKCB | 0.53628507 |
122 | TEC | 0.51978446 |
123 | CDK11A | 0.51620768 |
124 | MAPK10 | 0.50743551 |
125 | FYN | 0.49956792 |
126 | RPS6KA2 | 0.46668800 |
127 | IRAK1 | 0.46650548 |
128 | CAMK2D | 0.45920386 |
129 | GRK6 | 0.45289763 |
130 | PLK2 | 0.44957804 |
131 | PRKCE | 0.44500297 |
132 | FER | 0.44110512 |
133 | GRK7 | 0.44091853 |
134 | ADRBK2 | 0.43633948 |
135 | DYRK1A | 0.42750816 |
136 | MAP3K12 | 0.42647627 |
137 | ERBB4 | 0.41377316 |
138 | ADRBK1 | 0.40413936 |
139 | PRKACG | 0.40206294 |
140 | RIPK1 | 0.40004463 |
141 | PTK2B | 0.39978017 |
142 | MAP2K1 | 0.39808909 |
143 | BRAF | 0.39791584 |
144 | MAP2K2 | 0.39322801 |
145 | PIK3CA | 0.38632427 |
146 | PLK1 | 0.38275369 |
147 | PRKACA | 0.36908414 |
148 | ERBB3 | 0.36104675 |
149 | ERBB2 | 0.35317173 |
150 | PRKG1 | 0.35189110 |
151 | WNK3 | 0.35072075 |
152 | CSNK1A1 | 0.34613390 |
153 | MARK3 | 0.34258607 |
154 | GSK3B | 0.33629385 |
155 | PRKAA1 | 0.33273341 |
156 | PRKAA2 | 0.33025200 |
157 | MAPK8 | 0.32981697 |
158 | MUSK | 0.32514979 |
159 | PRKCA | 0.32078987 |
160 | HCK | 0.31908080 |
161 | TAF1 | 0.30648518 |
162 | CSNK1D | 0.29098127 |
163 | CHUK | 0.26243948 |
164 | EIF2AK3 | 0.25066321 |
165 | CDK3 | 0.24877548 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Phototransduction_Homo sapiens_hsa04744 | 6.59796806 |
2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.84590716 |
3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.62719627 |
4 | Morphine addiction_Homo sapiens_hsa05032 | 2.88379042 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72869148 |
6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.71482301 |
7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.70181704 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63752447 |
9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.54723720 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.45104618 |
11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.37950255 |
12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.36335329 |
13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.33019215 |
14 | Protein export_Homo sapiens_hsa03060 | 2.27907091 |
15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.25901366 |
16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.25408418 |
17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.24323001 |
18 | * Cocaine addiction_Homo sapiens_hsa05030 | 2.19731925 |
19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.15529945 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15518281 |
21 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13673305 |
22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.07781677 |
23 | Parkinsons disease_Homo sapiens_hsa05012 | 2.02554679 |
24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86127155 |
25 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84148333 |
26 | Insulin secretion_Homo sapiens_hsa04911 | 1.83220692 |
27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78739807 |
28 | Renin secretion_Homo sapiens_hsa04924 | 1.78091822 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75825060 |
30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74742873 |
31 | Salivary secretion_Homo sapiens_hsa04970 | 1.74409596 |
32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70089621 |
33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.66392518 |
34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65537169 |
35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60562440 |
36 | RNA polymerase_Homo sapiens_hsa03020 | 1.55966298 |
37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53871848 |
38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51051849 |
39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49249591 |
40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46251732 |
41 | Homologous recombination_Homo sapiens_hsa03440 | 1.42736768 |
42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41774285 |
43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.40570966 |
44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.35925407 |
45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.35748369 |
46 | Taste transduction_Homo sapiens_hsa04742 | 1.34575552 |
47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33189231 |
48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31887777 |
49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.29533826 |
50 | Peroxisome_Homo sapiens_hsa04146 | 1.29002160 |
51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.28793146 |
52 | Gap junction_Homo sapiens_hsa04540 | 1.26364314 |
53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24069943 |
54 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21805005 |
55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21781394 |
56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20672002 |
57 | Long-term depression_Homo sapiens_hsa04730 | 1.19894666 |
58 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.14879194 |
59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13455095 |
60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13032104 |
61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12978128 |
62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12187889 |
63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.11029606 |
64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.08719576 |
65 | RNA degradation_Homo sapiens_hsa03018 | 1.07780246 |
66 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07298572 |
67 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06919940 |
68 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05890389 |
69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05408334 |
70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04379177 |
71 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03669151 |
72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00494457 |
73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95855209 |
74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94613928 |
75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.92373313 |
76 | Glioma_Homo sapiens_hsa05214 | 0.91665174 |
77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.90943148 |
78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90374837 |
79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89964464 |
80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.89561190 |
81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89419956 |
82 | Alcoholism_Homo sapiens_hsa05034 | 0.88220369 |
83 | Proteasome_Homo sapiens_hsa03050 | 0.87433060 |
84 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.85611986 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84999580 |
86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83952223 |
87 | ABC transporters_Homo sapiens_hsa02010 | 0.82983635 |
88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82351987 |
89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77562965 |
90 | Purine metabolism_Homo sapiens_hsa00230 | 0.77076820 |
91 | Melanogenesis_Homo sapiens_hsa04916 | 0.77071496 |
92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75675892 |
93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75374661 |
94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74141913 |
95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73913620 |
96 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71349734 |
97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71269915 |
98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.71042695 |
99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69736560 |
100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69623971 |
101 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69604757 |
102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68176737 |
103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68015944 |
104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68013065 |
105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66097900 |
106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66063082 |
107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65208838 |
108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64725270 |
109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64030196 |
110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.63251548 |
111 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.62984552 |
112 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.62633075 |
113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62001192 |
114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61578712 |
115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59958833 |
116 | Axon guidance_Homo sapiens_hsa04360 | 0.59739830 |
117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56423221 |
118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55309627 |
119 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.54699040 |
120 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54125073 |
121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52709049 |
122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52651574 |
123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52486204 |
124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52270993 |
125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51973310 |
126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50917036 |
127 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50532490 |
128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50194259 |
129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50155534 |
130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49805609 |
131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49732517 |
132 | Mineral absorption_Homo sapiens_hsa04978 | 0.49582824 |
133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47154689 |
134 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46521440 |
135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44917734 |
136 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.44416024 |
137 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44236190 |
138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42812955 |
139 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41731397 |
140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.41548448 |
141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41430380 |
142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41305852 |
143 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.40191189 |
144 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39177024 |
145 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37769311 |
146 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37513228 |
147 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36660076 |
148 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36656346 |
149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36584563 |
150 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36447549 |
151 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36125188 |
152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36118127 |
153 | Endocytosis_Homo sapiens_hsa04144 | 0.33621105 |
154 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33126243 |
155 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30676832 |
156 | Platelet activation_Homo sapiens_hsa04611 | 0.30257838 |
157 | Bile secretion_Homo sapiens_hsa04976 | 0.29173614 |
158 | Prion diseases_Homo sapiens_hsa05020 | 0.28185854 |
159 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.28008442 |
160 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26324641 |
161 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26234452 |
162 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.25048937 |
163 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.23434766 |
164 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.23398547 |
165 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21690357 |
166 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.20647175 |
167 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20304107 |